This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Ocugen Inc. (OCGN) advanced 1.86% to $7.67 Monday, on what proved to be an all-around mixed trading session for the stock market, with the Dow Jones Industrial Average rising 0.21% to 34,869.37 and the S&P 500 Index falling 0.28% to 4,443.11. Ocugen Inc. closed $11.10 below its 52-week high ($18.77), which the company achieved on February 8th.
The stock underperformed when compared to some of its competitors Monday, as Adverum Biotechnologies Inc. (ADVM) rose 6.28% to $2.37, Ocular Therapeutix Inc. (OCUL) rose 3.24% to $10.83, and Kodiak Sciences Inc. (KOD) rose 4.84% to $106.94. Trading volume (10.3 M) remained 2.8 million below its 50-day average volume of 13.0 M.
Data source: Dow Jones Market Data, FactSet. Data compiled September 27, 2021.
(END) Dow Jones Newswires
September 27, 2021 17:13 ET (21:13 GMT)
Copyright (c) 2021 Dow Jones & Company, Inc.